Enriching People’s Lives by Providing Free Rare Disorders Tests in Hong Kong Articles

Back

The atypical hemolytic uremic syndrome (aHUS) is a rare life-threatening and aggressive disorder that causes tiny blood clots to form in the small blood vessels of the body. These blood clots can block blood flow to important organs and may lead to damage and blockage of small blood vessels, blood cell destruction, and multiorgan dysfunctions, predominantly in the kidneys.

To help patients shorten the diagnostic time and to precisely trace for aHUS, DKSH has collaborated with the Hong Kong Pharmaceutical Care Foundation to provide free ADAMTS13 diagnostic tests. The test distinguishes thrombotic thrombocytopenic purpura from other thrombotic microangiopathies and helps determine the pretest probability of ADAMTS13 deficiency.

As part of the sponsorship commitment, we helped introduce new medical treatments, improve patients' accessibility, participate in government communication programs, and organized public awareness events in Hong Kong.

At DKSH, our purpose is to enrich people’s lives. We do so by providing reliable access to high-quality and responsible products and services, creating sustainable value for our partners, and contributing to raising the quality of life in the communities we operate in by generating jobs, perspectives, and opportunities for people’s development and growth.